Pharmacological activities of Genistein, an isoflavone from soy (Glycine max): Part I - Anti-cancer activity

Indian Journal of Experimental Biology

Volumn 39, Issue 6, 2001, Pages 511-519

  Suthar, A C ^a   Banavalikar, M M ^a   Biyani, M K ^a  

^a Ajanta Pharma Ltd   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CARDIOVASCULAR SYSTEM; DISEASES; TUMORS;

PHYTOESTROGENS;

PLANTS (BOTANY);

GLYCINE MAX;

ANTINEOPLASTIC AGENT; GENISTEIN;

ANIMAL; CHEMISTRY; HUMAN; ISOLATION AND PURIFICATION; REVIEW; SOYBEAN;

ANIMAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; GENISTEIN; HUMAN; SOYBEANS;

EID: 0034982227     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. Clinical Review 97: Potential health benefits of dietary phytoestrogens: A review of the clinical, epidemiological, and mechanistic evidence
2. Dietary soy intake and urinary isoflavone excretion among women from a multiethnic population
3. Soybean phytoestrogen intake and cancer risk
4. Environmental factors and cancer incidence in different countries, with special reference to dietary practices
5. Soy intake and cancer risk: A review of the in vitro and in vivo data
6. Phyto-oestrogens: Where are we now?
7. Genistein inhibition of the growth of human breast cancer cells: Independence from estrogen receptors and the multi-drug resistance gene
8. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women
9. Naturally occurring estrogens in foods-a review
10. Development of a high-performance liquid chromatographic method for the analysis of phytoestrogens
11. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta
12. Estrogenic and antiproliferative properties of Genistein and other flavonoids in human breast cancer cells in vitro
13. Estrogens of vegetable origin
14. Relationship of Genistein with human estrogen
15. Growth factor receptor tyrosine kinases
16. The natural tyrosine kinase inhibitor Genistein inhibits growth and adhesion of sarcoma cell lines in vitro
17. Genistein a specific inhibitor of tyrosine-specific protein kinases
18. Antioxidant and antipromotional effects of the soybean isoflavone genistein
19. The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells
20. Genistein-induced cell differentiation and protein-linked DNA strand breakage in human melanoma cells
21. Effect of genistein on topoisomerase activity and on the growth of [Val 12]Ha-ras-transformed NIH 3T3 cells
22. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II
23. Genistein, a dietary-derived inhibitor of in vitro angiogenesis
24. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis
25. Effects of soyprotein supplementation on epithelial proliferation in the histologically normal human breast
26. Antioxidant activity of phytoestrogenic isoflavones
27. Inhibition of UV light- and Fenton reaction-induced oxidative DNA damage by the soybean isoflavone Genistein
28. Inhibition of aberrant proliferation and induction of apoptosis in preneoplastic human mammary epithelial cells by natural phytochemicals
29. Genistein modulates neuroblastoma cell proliferation and differentiation through induction and regulation of tyrosine kinase activity and N-mycexpression
30. Genistein induced growth inhibition and apoptosis in squamous cell carcinoma cell line of the head and neck
31. Inhibition of growth and induction of differentiation of metastatic melanoma cells in vitro by Genistein: Chemosensitivity is regulated by cellular p53
32. Acceleration of MRP-associated efflux of rhodamine 123 by Genistein and related compounds
33. Reversal of multidrug resistance by tyrosine-kinase inhibitors in non- P-glycoprotein-mediated multidrug-resistant cell line
34. Genistein modulates the decreased drug accumulation in non- P-glycoprotein mediated multidrug resistant tumor cells
35. Mechanism for the suppression of the mammalian stress response by Genistein, an anticancer phytoestrogen from soy
36. Prepubertal Genistein exposure suppresses mammary cancer and enhances differentiation in rats
37. Estrogenic and antiproliferative activities of MCF-7 human breast cancer cells by flavonoids
38. Phytoestrogens have agonistic and combinatorial effects on estrogen-responsive gene expression in MCF-7 human breast cancer cells
39. Curcumin and Genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MFC-7 cells induced by estrogenic pesticides
40. Inhibition of 17beta-hydroxysteroid by flavonoids in breast and prostate cancer cells
41. Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen
42. Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells
43. In vivo toxicity, pharmacokinetics, and anticancer activity of Genistein linked to recombinant human epidermal growth factor
44. Genistein exerts multiple suppressive effects on human breast carcinoma cells
45. Differential effect of Genistein on transforming growth factor beta 1 expression in normal and malignant mammary epithelial cells
46. Case-control study of phyto-estrogens and breast cancer
47. The chemopreventive properties of soy isoflavonoids in animal models of breast cancer
48. Genistein inhibits proliferation similar in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by P21WAF1/CIP1 induction, G2/M arrest, and apoptosis
49. Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells
50. Effects of soya consumption for one month on steroid hormones in premenopausal women: Implication for breast cancer risk reduction
51. Geographic pathology of latent prostatic cancer
52. Latent carcinoma of prostate cancer at autopsy in seven areas
53. Plasma concentrations of phyto-oestrogens in Japanese men
54. Lignans and isoflavones in plasma and prostatic fluid in men: Samples from Potuga, Hong Kong, and the United Kingdom
55. Inhibitory effects of dietary isoflavones on cell proliferation and c-myc expression in LNCaP human prostate cancer
56. Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture
57. Genistein inhibits proliferation and in vitro invasive potential of human prostatic cell lines
58. Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer line LNCaP
59. Growth inhibition of prostate cell lines in vitro by phyto-oestrogens
60. Genistein induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity
61. Genistein, a component of soy, inhibits the expression of the EGF and RrbB2/Neu receptors in the rat dorsolateral prostate
62. New sensitive discovery histoculture model for growth-inhibition studies in prostate cancer and BPH
63. Rational for the use of Genistein-containing soy matrices in chemoprevention trails for breast and prostate cancer
64. Colorectal cancer and the consumption of food: A case-control study in Belgium
65. Cancer chemoprevention agent development strategies for Genistein
66. Differential effects of Genistein and Daidzein on growth of human colon cancer cell lines
67. Efficacy of antiproliferative flavonoids on ascorbic acid accumulation in human colon adenocarcinoma cells
68. Synergistic action of Tiazofurin and Genistein in human ovarian carcinoma cells
69. Association of soy and fiber consumption with the risk of endometrial cancer
70. Stimulation of cis-diamminedichloroplatinum(II) accumulation by modulation of passive permeability with Genistein: An altered response in accumulation-defective resistant cells
71. Genistein inhibits growth of B 16 melanoma cells in vivo and in vitro and promotes differentiation in vitro
72. Isoflavone Genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice
73. Cell differentiation and cell-cycle alterations by tyrosine kinase inhibitors in human melanoma cells
74. Photoprotective action of isoflavone genistein: Models, mechanisms, and relevance to clinical dermatology
75. Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in no-small-cell lung cancer cell line
76. Effect of isoflavone Genistein and Daidzein in the inhibition of lung metastasis in mice induced by B16F-10 melanoma cells
77. Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents
78. Inhibition of tyrosine kinase activity decreases expression of surfactant protein A in a human lung adenocarcinoma cell line independent of epidermal growth factor receptor
79. Large scale manufacturing of B43(anti-CD19)-Genistein for clinical trials in leukemia and lymphoma
80. Modulation of methotrexate resistance by Genistein in muring leukemia L1210 cells
81. Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells
82. Down-modulation of P210bcr/abl induces apoptosis/differentiation in K562 leukemic blast cells
83. Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells
84. Inhibition of murine bladder turmorigenesis by soy isoflavones via alteration in the cell cycle, apoptosis, and angiogenesis
85. Inhibition of human bladder cancer cell motility by Genistein is dependent on epidermal growth factor receptor but not p21ras gene expression
86. Suppression of the proliferation and migration of oncogenic ras-dependent cell lines, cultured in a three-dimensional collagen matrix, by flavonoid-structured molecules